NCT05521789RecruitingPhase 4
Erector Spinae Block for Thoracic Surgery
Erector Spinae Blocks for Thoracic Surgery
Source: ClinicalTrials.gov · Last updated 25 Feb 2026
Brief summary (registry, in English)
The aim of this study is to determine if erector spinae injections with bolus infusions with local anesthetic decrease postsurgical pain and opioid consumption in patients undergoing pulmonary resection surgery.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- First submitted
- 23 Aug 2022
- Start date
- 22 Jul 2022
- Primary completion date
- 21 Dec 2026
- Lead sponsor
- George Washington University
- NCT number
- NCT05521789
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 70
- From 22 Jul 2022 to the primary completion date, 21 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- emergent surgery
- bilateral pulmonary resection
Other illness
- local anesthetic allergy
- intraoperative complication (inadvertent hemorrhage or conversion to open surgery)
Other
- pleurodesis
- decortication
Who the study is looking for
- pulmonary resection
- 18\<age\<90
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The George Washington University Coordinator of this site? Confirm its status | Washington D.C. | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.